NewAmsterdam Pharma Company N.V. (NAMS)
NASDAQ: NAMS · Real-Time Price · USD
35.46
+1.18 (3.44%)
At close: Feb 27, 2026, 4:00 PM EST
35.28
-0.18 (-0.51%)
After-hours: Feb 27, 2026, 7:33 PM EST
NAMS Employees
NewAmsterdam Pharma Company had 100 employees as of December 31, 2025. The number of employees increased by 32 or 47.06% compared to the previous year.
Employees
100
Change (1Y)
32
Growth (1Y)
47.06%
Revenue / Employee
$225,030
Profits / Employee
-$2,038,190
Market Cap
4.08B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 100 | 32 | 47.06% |
| Dec 31, 2024 | 68 | 39 | 134.48% |
| Dec 31, 2023 | 29 | 12 | 70.59% |
| Dec 31, 2022 | 17 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Corcept Therapeutics | 730 |
| ADMA Biologics | 685 |
| ACADIA Pharmaceuticals | 654 |
| Crinetics Pharmaceuticals | 437 |
| TG Therapeutics | 374 |
| Alumis | 223 |
| Structure Therapeutics | 218 |
| Centessa Pharmaceuticals | 114 |
NAMS News
- 3 days ago - NewAmsterdam Pharma to Participate at Upcoming Investor Conferences in March - GlobeNewsWire
- 10 days ago - NewAmsterdam Pharma Reports Full Year 2025 Financial Results and Provides Corporate Update - GlobeNewsWire
- 22 days ago - NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 24 days ago - NewAmsterdam Pharma to Present at the Guggenheim Emerging Outlook: Biotech Summit - GlobeNewsWire
- 7 weeks ago - NewAmsterdam Pharma Highlights 2025 Achievements and Outlines 2026 Strategic Priorities - GlobeNewsWire
- 3 months ago - NewAmsterdam Pharma Company N.V. (NAMS) Presents at Citi Annual Global Healthcare Conference 2025 Transcript - Seeking Alpha
- 3 months ago - NewAmsterdam Pharma to Participate at Upcoming Investor Conferences in December - GlobeNewsWire
- 3 months ago - NewAmsterdam: Obicetrapib MAA Filings Merit Continued 'Buy' Rating - Seeking Alpha